Grandfield & Dodd’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.46M | Buy |
|
|||||
|
2025
Q2 | $1.47M | Sell |
|
|||||
|
2025
Q1 | $1.14M | Buy |
|
|||||
|
2024
Q4 | $1.25M | Buy |
|
|||||
|
2024
Q3 | $1.39M | Buy |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $1.46M | Buy |
|
|||||
|
2023
Q4 | $1.67M | Buy |
|
|||||
|
2023
Q3 | $1.49M | Buy |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $1.15M | Buy |
|
|||||
|
2022
Q4 | $1.19M | Buy |
|
|||||
|
2022
Q3 | $1.29M | Buy |
|
|||||
|
2022
Q2 | $1.05M | Buy |
|
|||||
|
2022
Q1 | $1.04M | Buy |
|
|||||
|
2021
Q4 | $810K | Buy |
|
|||||
|
2021
Q3 | $730K | Buy |
|
|||||
|
2021
Q2 | $840K | Buy |
|
|||||
|
2021
Q1 | $920K | Buy |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $900K | Buy |
|
|||||
|
2020
Q2 | $1.1M | Buy |
|
|||||
|
2020
Q1 | $820K | Buy |
|
|||||
|
2019
Q4 | $1.01M | Buy |
|
|||||
|
2019
Q3 | $948K | Buy |
|
|||||
|
2019
Q2 | $942K | Buy |
|
|||||
|
2019
Q1 | $1.12M | Buy |
|
|||||
|
2018
Q4 | $743K | Buy |
|
|||||
|
2018
Q3 | $700K | Buy |
|
|||||
|
2018
Q2 | $561K | Buy |
|
|||||
|
2018
Q1 | $590K | Sell |
|
|||||
|
2017
Q4 | $688K | Buy |
|
|||||
|
2017
Q3 | $678K | Buy |
|
|||||
|
2017
Q2 | $652K | Buy |
|
|||||
|
2017
Q1 | $487K | Buy |
|
|||||
|
2016
Q4 | $573K | Buy |
|
|||||
|
2016
Q3 | $381K | Sell |
|
|||||
|
2016
Q2 | $260K | Buy |
|
|||||
|
2016
Q1 | $349K | Buy |
|
|||||
|
2015
Q4 | $333K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $213K | Buy |
|